Granulocyte macrophage-colony stimulating factor reciprocally regulates alphav-associated integrins on murine osteoclast precursors.
The integrins alphavbeta3 and alphavbeta3 are expressed reciprocally during murine osteoclastogenesis in vitro. Specifically, immature osteoclast precursors, in the form of bone marrow macrophages, contain exclusively alphavbeta5, surface expression of which declines with commitment to the osteoclast phenotype, while levels of alphavbeta3 increase concomitantly. The distinct functional significance of alphavbeta5 is underscored by the integrin's capacity, unlike alphavbeta3, to mediate both attachment and spreading on ligand, of marrow macrophages, suggesting alphavbeta3 negotiates initial recognition, by osteoclast precursors, of bone matrix. Northern analysis demonstrates changes in the two beta-subunits, and not alphav, are responsible for these alterations. Treatment of early precursors with granulocyte-macrophage colony stimulating factor (GM-CSF) leads to alterations in beta3 and beta5 mRNA and alphavbeta5 and alphavbeta3, paralleling those occurring during osteoclastogenesis. Nuclear run-on and message stability studies demonstrate that while GM-CSF treatment of precursors alters beta5 transcriptionally, the changes in beta3 arise from prolonged mRNA t1/2. Similar to GM-CSF treatment, the rate of beta5 transcription falls during authentic osteoclastogenesis. In contrast to cytokine-induced alphavbeta3, however, that attending osteoclastogenesis reflects accelerated transcription of the beta3-subunit. Thus, while GM-CSF may participate in modulation of alphavbeta5 during osteoclast differentiation, signals other than those derived from the cytokine must regulate expression of alphavbeta3.
Inoue
M
M
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Namba
N
N
Chappel
J
J
Teitelbaum
S L
SL
Ross
F P
FP
D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D005786:Gene Expression Regulation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology*; D016023:Integrins / Q000235:genetics* / Q000502:physiology; D007700:Kinetics; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D010010:Osteoclasts / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D019030:Receptors, Vitronectin / Q000235:genetics* / Q000502:physiology; D013234:Stem Cells / Q000378:metabolism*; D014158:Transcription, Genetic
D016023:Integrins; D012333:RNA, Messenger; D019030:Receptors, Vitronectin; C064660:integrin alphaVbeta5; D016178:Granulocyte-Macrophage Colony-Stimulating Factor